Showing results (11-20 of 121) with videos related to
Sort By:
Pageof 13
Discovery Medicine|September 1, 2015
Combination of anti-angiogenesis agents and transarterial embolization: Is it a promising approach for the treatment of liver cancer?Zhengfeng Wang, Wence Zhou, Hui Zhang, et al.Expert Review of Gastroenterology & Hepatology|June 10, 2022
The relationships between antihypertensive medications and the overall survival of patients with pancreatic cancer: a systematic review and meta-analysisWenkai Jiang, Ru He, Yongyan Lu, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 13, 2021
Betulinic acid in the treatment of tumour diseases: Application and research progressWenkai Jiang, Xin Li, Shi Dong, et al.Biomolecules|September 28, 2024
Natural Compounds for the Treatment of Acute Pancreatitis: Novel Anti-Inflammatory TherapiesWenkai Jiang, Xiao Li, Yi Zhang, et al.Cancer Letters|August 29, 2013
Hepatitis B virus-induced hepatocellular carcinomaCheng Xu, Wence Zhou, Yuming Wang, et al.Frontiers in Oncology|July 6, 2023
Pancreatic stellate cells in pancreatic cancer: as potential targets for future therapyZhengfeng Wang, Ru He, Shi Dong, et al.Molecular Medicine Reports|February 16, 2024
Research advances of MAL family members in tumorigenesis and tumor progression (Review)Mengyao Li, Yan Du, Xianzhuo Zhang, et al.Biochemical Pharmacology|July 29, 2026
Cordycepin inhibits pancreatic cancer progression and enhances gemcitabine sensitivity by targeting the CDK2/E2F2 axis to modulate TNNI2 expressionRu He, Yan Du, Wenkai Jiang, et al.Biomed Research International|October 16, 2020
Alterations of the Bile Microbiome in Recurrent Common Bile Duct StoneCheng Ye, Wence Zhou, Hui Zhang, et al.Journal of Clinical Laboratory Analysis|April 11, 2022
Integrated bioinformatics analysis of potential biomarkers for pancreatic cancerHuaqing Shi, Hao Xu, Changpeng Chai, et al.Pageof 13